Home
News
Videos
Podcasts
Menu
Акционерное общество "ТВ БРИКС"
tvbrics@tvbrics.com
Рубцов переулок, д.13, Москва, 105082, RU
+74996425304
Currencies:
RUB/USD 0,0121
0,0000
BRL/USD 0,1962
0,0002
INR/USD 0,0105
0,0000
CNY/USD 0,1479
0,0005
ZAR/USD 0,0616
0,0003
IDR/USD 0,0001
0,0000
SPACE FOR MEDIA DIPLOMACY
07:15 «BRICSterview»
07:15 «BRICSterview»
Now 16+
07:15

«BRICSterview»

It is indicated Moscow time in the programme. Please take into account the time difference with your time zone.
07:45 «BRICSdialogue»
Next
07:45

«BRICSdialogue»

16+
08:15

«Laboratorium»

16+
08:30

«Lеt's be clear»

16+
Menu
Broadcast «BRICSterview»
RUB/USD
0,0121
0,0000
BRL/USD
0,1962
0,0002
INR/USD
0,0105
0,0000
CNY/USD
0,1479
0,0005
ZAR/USD
0,0616
0,0003
IDR/USD
0,0001
0,0000
TV BRICS Apps
India’s pharmaceutical sector ranks among global leaders as exports and production surge

Strong growth, global supply dominance and policy support drive industry expansion


India has emerged as one of the world’s leading pharmaceutical producers, ranking third globally by volume and 11th by value, according to the latest official data highlighting the sector’s rapid expansion and growing international footprint, reports IANS, a partner of TV BRICS.

The country’s pharmaceutical industry now comprises more than 3,000 companies and over 10,500 manufacturing units, forming a highly integrated ecosystem supported by policy reforms, innovation and rising global demand. The domestic market, currently valued at around US$60 billion, is projected to more than double to US$130 billion by 2030.

Pharmaceutical exports alone totalled US$30.5 billion in 2024–25, marking a nearly 16-fold increase since the early 2000s.

India remains the world’s largest supplier of generic medicines, accounting for approximately 20 per cent of global supply and producing tens of thousands of formulations across a wide range of therapeutic categories. The country also plays a critical role in global vaccination efforts, supplying a significant share of essential vaccines used in international immunisation programmes supported by organisations such as UNICEF and the World Health Organisation.

In addition, the country has a significant presence in the production of active pharmaceutical ingredients, contributing around 8 per cent of global output. Ongoing and proposed trade agreements with major international partners are expected to further enhance market access and strengthen India’s position within global healthcare supply chains.